Implitapide Uses, Dosage, Side Effects and more
Implitapide is a microsomal triglyceride transfer protein (MTP)-inhibitor.
Implitapide is an inhibitor of microsomal triglyceride transfer protein (MTP), a key enzyme involved in the assembly and release of cholesterol and triglyceride from the liver and intestinal tract. It is being investigated for the treatment of atherosclerosis.
| Attribute | Details |
|---|---|
| Trade Name | Implitapide |
| Generic | Implitapide |
| Implitapide Other Names | Implitapide |
| Type | |
| Formula | C35H37N3O2 |
| Weight | Average: 531.6872 Monoisotopic: 531.288577443 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
For the treatment of atherosclerosis.
How Implitapide works
MTP mediates triglyceride absorption and chylomicron secretion from the intestine and very-low-density lipoprotein (VLDL) secretion from the liver by linking lipid molecules with apolipoprotein B (apoB). Inhibition of MTP reduces the level of all apoB-containing lipoproteins, including LDL.
